(Osi) Eyetech, Inc.
Records under this name other than patents (Osi) Eyetech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to (Osi) Eyetech, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,877,229 | Controlled release microparticles Formerly held In force · High confidence | In force | High confidence | |
| US 8,685,397 | Combination therapy for the treatment of ocular neovascular disorders Formerly held Lapsed on the fee record Ended Apr 1, 2022 · USPTO record | Lapsed on the fee record | Ended Apr 1, 2022 | USPTO record |
| US 8,206,707 | Combination therapy for the treatment of ocular neovascular disorders Formerly held Lapsed on the fee record Ended Jun 26, 2020 · USPTO record | Lapsed on the fee record | Ended Jun 26, 2020 | USPTO record |
| US 8,187,597 | Combination therapy for the treatment of ocular neovascular disorders Formerly held Lapsed on the fee record Ended May 29, 2020 · USPTO record | Lapsed on the fee record | Ended May 29, 2020 | USPTO record |
| US 7,759,472 | Combination therapy for the treatment of ocular neovascular disorders Formerly held Lapsed on the fee record Ended Jul 20, 2018 · USPTO record | Lapsed on the fee record | Ended Jul 20, 2018 | USPTO record |
| US 7,785,784 | Detection of oligonucleotides by dual hybridization Formerly held Lapsed on the fee record Ended Aug 31, 2014 · USPTO record | Lapsed on the fee record | Ended Aug 31, 2014 | USPTO record |